The revised guideline updates and replaces ‘Prostate cancer’ (NICE clinical guideline 58) first which was published in 2008.
Among the updated recommendations is a new protocol for active surveillance. This is a way of monitoring slow-growing prostate cancers that might never progress or cause any symptoms, and can help avoid or delay treatment such as radiotherapy or surgery which might otherwise be unnecessary.
The guideline also highlights the importance of information and decision support for men with prostate cancer, their partners and carers. It says that doctors should discuss all relevant management options recommended in the guideline with men with prostate cancer and their partners or carers, irrespective of whether they are available through local services.
Chair of the Guideline Development Group Dr John Graham said: “All treatments for prostate cancer have serious side effects which can affect the quality of life, especially their effects on erectile function, fertility and continence. This is why it is so important that men are able to understand the treatment options available to them and, with the support of their healthcare professional, are able to make a choice to suit their individual needs, both clinically and related to their quality of life.
“It is important that information and support is available and easily accessible to ensure patients can make the most appropriate decision for them in terms of treatment. This guideline acknowledges that, and makes recommendations about supportive care.”
Dr Sarah Cant, representing patients and carers on the Guideline Development Group, said: “We want to ensure that all men diagnosed with prostate cancer receive the same high level of care, no matter where they live. Men and their carers should be supported at all times by appropriately trained professionals who can explain all the treatment and support options that are available for them. By making sure information and support are important aspects of care, we hope that all men will be better able to make the treatment choices that are right for them.”
Download Clinical Guideline 175 Prostate cancer: diagnosis and treatment from the NICE website.
Leave a Reply